164 related articles for article (PubMed ID: 38018134)
1. Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience.
Hou Q; Wang Y; Zhang D; Luo Y; Dong L; Mu M; Yu J; Liang P
Technol Cancer Res Treat; 2023; 22():15330338231183585. PubMed ID: 38018134
[TBL] [Abstract][Full Text] [Related]
2. Survival benefits analyses of T1a renal cell carcinoma patients treated with microwave ablation.
Hou Q; Yu X; Cheng Z; Han Z; Liu F; Dou J; Yu J; Liang P
Eur J Radiol; 2021 Nov; 144():109951. PubMed ID: 34607288
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
4. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
6. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
7. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
8. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors.
Hao G; Hao Y; Cheng Z; Zhang X; Cao F; Yu X; Han Z; Liu F; Mu M; Dou J; Li X; Dupuy DE; Yu J; Liang P
Int J Hyperthermia; 2018; 35(1):62-70. PubMed ID: 29807450
[TBL] [Abstract][Full Text] [Related]
9. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
11. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous microwave ablation of renal masses in a UK cohort.
John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
[TBL] [Abstract][Full Text] [Related]
13. Comparison of microwave ablation and partial nephrectomy for T1a small renal masses.
Qiu J; Ballantyne C; Lange M; Kennady E; Yeaman C; Culp S; Schenkman N; Lobo JM
Urol Oncol; 2023 Oct; 41(10):434.e9-434.e16. PubMed ID: 37598044
[TBL] [Abstract][Full Text] [Related]
14. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Mu MJ; Li X; Wang XH
Radiology; 2014 Mar; 270(3):880-7. PubMed ID: 24475805
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
[TBL] [Abstract][Full Text] [Related]
16. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
[TBL] [Abstract][Full Text] [Related]
17. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced CT immediately following percutaneous microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes.
Koebe SD; Curci NE; Caoili EM; Triche BL; Dreyfuss LD; Allen GO; Brace CL; Davenport MS; Abel EJ; Wells SA
Abdom Radiol (NY); 2022 Aug; 47(8):2674-2680. PubMed ID: 35278110
[TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury after nephron sparing surgery and microwave ablation: focus on incidence, survival impact and prediction.
Hou Q; Yu X; Cheng Z; Han Z; Liu F; Dou J; An C; Chen X; Yu J; Liang P
Int J Hyperthermia; 2020; 37(1):470-478. PubMed ID: 32396482
[No Abstract] [Full Text] [Related]
20. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.
Ierardi AM; Puliti A; Angileri SA; Petrillo M; Duka E; Floridi C; Lecchi M; Carrafiello G
Med Oncol; 2017 May; 34(5):97. PubMed ID: 28421553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
